James N Atkins

James N Atkins

UNVERIFIED PROFILE

Are you James N Atkins?   Register this Author

Register author
James N Atkins

James N Atkins

Publications by authors named "James N Atkins"

Are you James N Atkins?   Register this Author

57Publications

1406Reads

20Profile Views

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.

J Clin Oncol 2017 Dec 26;35(35):3942-3948. Epub 2017 Oct 26.

All authors: National Surgical Adjuvant Breast and Bowel Project/NRG Oncology; Reena S. Cecchini, Priya Rastogi, Jong-Hyeon Jeong, and Adam M. Brufsky, University of Pittsburgh; Priya Rastogi and Adam M. Brufsky, Magee-Womens Hospital; Norman Wolmark, Allegheny Health Network Cancer Institute, Pittsburgh, PA; Patricia A. Ganz, University of California at Los Angeles, Los Angeles; Louis Fehrenbacher, Kaiser Permanente, Vallejo; Jonathan Polikoff, Kaiser Permanente, San Marco, CA; Edward H. Romond, University of Kentucky, Lexington, KY; Charles E. Geyer Jr, Virginia Commonwealth University, Richmond, VA; Sandra M. Swain and John L. Zapas, MedStar Washington Hospital Center, Washington, DC; Howard M. Gross, Dayton National Cancer Institute Community Oncology Research Program (NCORP), Dayton, OH; Patrick J. Flynn, Metro-Minnesota Community Clinical Oncology Program (CCOP), Woodbury, MN; Tanya A. Wahl, Fred Hutchinson Cancer Research Center, Seattle, WA; Thomas E. Seay, Atlanta Regional CCOP, Atlanta, GA; James L. Wade III, Heartland NCORP, Decatur, IL; David D. Biggs, Christiana Care Health System, Newark, DE; James N. Atkins, Southeast Clinical Oncology Research Consortium NCORP, Goldsboro, NC; and Eleftherios P. Mamounas, Orlando Health, Orlando, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721228PMC
December 2017

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

N Engl J Med 2015 Nov 27;373(21):2005-14. Epub 2015 Sep 27.

From the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana-Farber Cancer Institute, Boston (R.J.G.); Sunnybrook Research Institute, Toronto (K.I.P.) and Juravinski Cancer Center, Hamilton, ON (T.J.W.) - both in Canada; Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.); University of North Carolina, Chapel Hill (E.C.D.), Duke University Medical Center, Durham (J.A.O.), Wake Forest University Health Service, Winston-Salem (L.I.W.), and Southeast Clinical Oncology Research Consortium, Goldsboro (J.N.A.) - all in North Carolina; Mayo Clinic, Jacksonville, FL (E.A.P.); University of Maryland School of Medicine, Baltimore (J.A.O.), and National Institutes of Health, Bethesda (J.Z., T.L.) - both in Maryland; Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.) - both in Indianapolis; Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin; Baylor College of Medicine, Houston (M.J.E.), and University of Texas, San Antonio (P.R.) - both in Texas; Washington University, St. Louis (M.J.E.); Allegheny General Hospital (S.P.) and University of Pittsburgh (A.M.B.) - both in Pittsburgh; the Department of Medical Oncology and Breast Center, Yonsei University College of Medicine, Seoul, South Korea (S.P.); Emory University, Atlanta (W.C.W.); Irish Clinical Oncology Research Group, Dublin (M.M.K.); Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.M.); Cancer Center of Kansas, Wichita (P.S.R.); Vanderbilt University, Nashville (I.A.M.); Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.); University of Hawaii Cancer Center, Honolulu (J.L.B.); and Stanford University, Stanford, CA (G.W.S.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1510764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701034PMC
November 2015

Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04.

Ann Surg 2015 Jan;261(1):144-8

*National Surgical Adjuvant Breast and Bowel Project (NSABP) Operations and Biostatistical Centers, Pittsburgh, PA †David Geffen School of Medicine at UCLA, VA Greater Los Angeles Healthcare System, Los Angeles, CA ‡UCLA Schools of Medicine & Public Health and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA §University of Pittsburgh Graduate School of Public Health Department of Biostatistics, Pittsburgh, PA ∥UCLA, Los Angeles, CA ¶Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA **Southeast Cancer Control Consortium CCOP, Goldsboro, NC ††University of Pittsburgh Medical Center, Pittsburgh, PA ‡‡Missouri Valley Cancer Consortium CCOP, Omaha, NE §§Beaumont Hospital System, Royal Oak, MI ∥∥Florida Cancer Specialists, Sarasota, FL ¶¶Montana Cancer Consortium, Billings, MT ***Helen F. Graham Cancer Center, Newark, DE †††Glendale Memorial Hospital and Health Center, Glendale, CA ‡‡‡Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/annalsofsurgery/2015/01000/Comp
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/SLA.0000000000000594DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379325PMC
January 2015

Effects of yoga on cancer-related fatigue and global side-effect burden in older cancer survivors.

J Geriatr Oncol 2015 Jan 30;6(1):8-14. Epub 2014 Oct 30.

Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA; Department of Surgery, Cancer Control and Survivorship Program, University of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2014.09.184DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297736PMC
January 2015

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Cancer Genomics Proteomics 2013 May-Jun;10(3):93-113

Department of Radiation Oncology, The Brody School of Medicine at East Carolina University (ECU), Greenville, NC 27834, USA.

View Article

Download full-text PDF

Source
December 2013

Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.

J Clin Oncol 2013 Sep 12;31(26):3197-204. Epub 2013 Aug 12.

Sandra M. Swain, Gong Tang, Charles E. Geyer Jr, Priya Rastogi, James N. Atkins, Paul P. Donnellan, Louis Fehrenbacher, Catherine A. Azar, André Robidoux, Jonathan A. Polikoff, Adam M. Brufsky, David D. Biggs, Edward A. Levine, John L. Zapas, Louise Provencher, Soonmyung Paik, Joseph P. Costantino, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project (NSABP); Norman Wolmark, Allegheny General Hospital, Allegheny Health Network; Gong Tang and Joseph P. Costantino, NSABP Biostatistical Center and University of Pittsburgh Graduate School of Public Health; Priya Rastogi, University of Pittsburgh Cancer Institute; Adam M. Brufsky, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Charles E. Geyer Jr, Virginia Commonwealth University, Richmond, VA; James N. Atkins, Southeast Cancer Control Consortium-Community Clinical Oncology Program, Goldsboro; Edward A. Levine, Wake Forest University, Winston-Salem, NC; Paul P. Donnellan, University Hospital, Galway, and the All-Ireland Cooperative Oncology Research Group, Dublin, Ireland; Louis Fehrenbacher, Kaiser Permanente Northern California, Vallejo; Jonathan A. Polikoff, Kaiser Permanente Southern California, San Diego, CA; Catherine A. Azar, Kaiser Permanente, Denver, CO; André Robidoux, Centre hopitalier de l'Université de Montréal (CHUM), Montréal; Louise Provencher, CHU de Québec, Hôpital du Saint-Sacrement, Québec City, QC, Canada; David D. Biggs, Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE; John L. Zapas, Medstar Franklin Square Medical Center, Baltimore, MD; Donald W. Northfelt, Mayo Clinic Arizona, Scottsdale, AZ; and Eleftherios P. Mamounas, MD Anderson Cancer Center, Orlando, FL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2013/08/12/JCO.2012.48
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2012.48.1275
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.48.1275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757290PMC
September 2013

Diagnostic microRNA markers to screen for sporadic human colon cancer in blood.

Cancer Genomics Proteomics 2012 Jul-Aug;9(4):179-92

Department of Radiation Oncology, Leo W. Jenkins Cancer Center, The Brody School of Medicine at East Carolina University (ECU), Greenville, NC 27834, USA.

View Article

Download full-text PDF

Source
December 2012

Cancer clinical trials in North Carolina.

N C Med J 2008 Jul-Aug;69(4):306-8

Moses Cone Regional Cancer Center, USA.

View Article

Download full-text PDF

Source
November 2008

How do patient expectancies, quality of life, and postchemotherapy nausea interrelate?

Cancer 2008 Aug;113(3):654-61

Medical Psychology Research Unit, School of Psychology, University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23594DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079444PMC
August 2008

The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer.

J Thorac Oncol 2008 Feb;3(2):145-51

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318160c5f1DOI Listing
February 2008

Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.

J Thorac Oncol 2007 Jun;2(6):526-30

University of Utah Health Science Center, Huntsman Cancer Institute, Salt Lake City, Utah 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318060d2dcDOI Listing
June 2007

Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer.

J Thorac Oncol 2006 Oct;1(8):832-6

Comprehensive Cancer Center, Wake Forest University, Winston-Salem, North Carolina, USA.

View Article

Download full-text PDF

Source
October 2006

Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study.

Support Care Cancer 2006 Jul 16;14(7):732-41. Epub 2006 Feb 16.

Behavioral Medicine Unit, Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Box 704, 601 Elmwood Avenue, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-005-0912-6
Publisher Site
http://dx.doi.org/10.1007/s00520-005-0912-6DOI Listing
July 2006

Prevalence of complementary and alternative medicine use in cancer patients during treatment.

Support Care Cancer 2005 Oct 15;13(10):806-11. Epub 2005 Feb 15.

James P. Wilmot Cancer Center, University of Rochester, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-004-0770-7
Publisher Site
http://dx.doi.org/10.1007/s00520-004-0770-7DOI Listing
October 2005

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.

Cancer 2004 Jul;101(2):370-8

Department of Internal Medicine, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20362DOI Listing
July 2004

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community.

Cancer 2003 Jun;97(11):2880-6

University of Rochester Cancer Center (URCC) Community Clinical Oncology Program (CCOP) Research Base, University of Rochester James P. Wilmot Cancer Center, New York 14642, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.11408
Publisher Site
http://dx.doi.org/10.1002/cncr.11408DOI Listing
June 2003

Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07).

Int J Radiat Oncol Biol Phys 2002 Dec;54(5):1455-9

H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(02)03750-1DOI Listing
December 2002

Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma: a Cancer and Leukemia Group B study.

Cancer 2002 Feb;94(3):665-72

Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263-0001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.10217DOI Listing
February 2002